Dr. Myers is an experienced healthcare and biotech executive. He has served as Chief Medical Officer for both Portola Pharmaceuticals and Revolo Biotherapeutics before joining Bioceptive. Prior to beginning his career in biotechnology, he was a practicing congenital cardiac surgeon and served as the Chief of Pediatric Cardiac Surgery at Tulane University and Massachusetts General Hospital. He is passionate about developing novel,first-in-class therapies that significantly improve the lives of patients.
Principal inventor on Bioceptive's technologies. The platform device, a gentle suction-based device to replace the cervical tenaculum received FDA 510(k) clearance. The Bioceptive IUD Insertion System is in clinical testing currently.
Managing Director of Louisiana Funds (LF I & II), two early stage venture capital funds (total $40 million) based in Louisiana with offices in New Orleans and Baton Rouge. LF’s focus is on forming early stage companies primarily based on research at the major Louisiana research universities (LSU, Tulane and Louisiana Tech University) in the areas of biotechnology, life sciences, pharmaceuticals, medical devices, agri-technology, engineering, software, security and internet technologies.
Partner and Chief Financial Officer at Louisiana Fund with a demonstrated history of working in the venture capital and private equity industry. Strong business development professional skilled in Entrepreneurship, Venture Capital, IPO, Corporate Development, and Mergers & Acquisitions (M&A).